CDC was 0/3 on their choices this year. Chiron and Sanofi currently have the bid (I think). Unless, you pee at the same urinal or play the green with the big pharma boys, I doubt it is accurate. If you like, I can inquire as some of my colleagues sit on their board of directors - I would probably receive incredulous looks... Usually, pharma don't risk on GMP, but on IP stealing from each other.
Viruses are not "alive". However, in the flu shot the virus is usually rendered unable to replicate in a host by something such as a nasty organic - formaldehyde being an example. Of course, this is then chemically extracted and purified before use. There is also a "live" but attenuated aerosolised version , if that is what you are referring to BioZest.